{"disease":{"id":"relapsed-or-refractory-chronic-lymphocytic-leukemia-including-small-lymphocytic-lymphoma","name":"relapsed or refractory chronic lymphocytic leukemia including small lymphocytic lymphoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04872621","title":"Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation","phase":"","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"AstraZeneca","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}